Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.

Also called NCT03329599

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 148 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03329599
Other papers using this trial's data
  • A cardiovascular polypill for secondary stroke prevention in a tertiary centre in Ghana (SMAART): a phase 2 randomised clinical trial The Lancet. Global health, 2023-10 DOI, PubMed 37734804, PMC10576526 In the PMC Open Access subset under CC BY-NC-ND.
  • Effect of a Cardiovascular Polypill on Poststroke Cognition Among Ghanaians: Secondary Analysis of a Randomized Clinical Trial Journal of the American Heart Association, 2024-08-06 DOI, PubMed 39082406, PMC11964051 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Ghana (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03329599. Randomized; quadruple masking; primary purpose treatment. Start 2019-02-14 (actual); primary completion 2021-12-01 (actual). Results posted on 2023-12-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment
Condition
Atherosclerosis
Condition
Adherence, Medication
Condition
Tolerance
Intervention (Drug)
Polycap
Lead sponsor
Northern California Institute of Research and Education (class: other)
Collaborator
Kwame Nkrumah University Teaching Hospital (class: other)

Record details

Record id
cardio:ct-nct03329599
Content hash
b14da09d6155f578719a6c062c3c1b92a3fad0257b4425a18533eddf2a52772e